Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,36,1.02 [0.98-1.06],0.321213584358401
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,36,1.12 [0.97-1.30],0.133552469869811
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,36,1.01 [0.89-1.15],0.854063082328696
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,36,0.84 [0.70-1.01],0.0618202488641824
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,36,0.98 [0.92-1.06],0.660602882360103
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,36,0.98 [0.90-1.07],0.629759909484938
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,36,1.00 [0.91-1.11],0.967963704536384
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,36,0.93 [0.87-1.00],0.0515763315877835
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,36,1.01 [0.92-1.12],0.777999852480129
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,36,0.99 [0.91-1.07],0.753589424781165
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,36,0.99 [0.91-1.08],0.871151148808798
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,36,1.05 [0.93-1.18],0.430354484516992
TACSTD2,Tumor-associated calcium signal transducer 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,Inverse variance weighted,36,1.04 [0.99-1.09],0.0831394408973856
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,36,1.01 [0.95-1.07],0.85784722346036
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,36,0.96 [0.83-1.10],0.512401140869825
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,36,0.98 [0.84-1.15],0.814858040265453
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,36,1.06 [0.96-1.18],0.256201061104534
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,36,0.97 [0.90-1.05],0.449106338816087
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,36,1.03 [0.93-1.14],0.614959680817753
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,36,0.98 [0.85-1.13],0.806650639569714
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,36,1.00 [0.95-1.05],0.900213742078953
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,36,0.98 [0.87-1.10],0.695169078024675
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,36,0.96 [0.90-1.02],0.148457647280715
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,36,0.88 [0.76-1.01],0.0673249275668675
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,36,0.98 [0.93-1.02],0.328236109653377
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,36,0.90 [0.77-1.05],0.193686042847785
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,36,1.05 [0.97-1.14],0.26789987669393
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,36,0.98 [0.96-1.01],0.18176663063377
TACSTD2,Tumor-associated calcium signal transducer 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,36,0.96 [0.88-1.05],0.343040909362457
